Back to Journals » Breast Cancer: Targets and Therapy

Breast Cancer: Targets and Therapy

ISSN: 1179-1314


Journal Articles:

- 424 records -

Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis

Liu Y, Tang J, Qiu X, Teng LA, Sriwastva MK, Han X, Li Z, Liu M, Liu S, Da D, Li Z, Zhen L, Ren Y

Breast Cancer: Targets and Therapy 2023, 15:403-419

Published Date: 30 May 2023

Transcriptome Profiling Analysis of Breast Cancer Cell MCF-7 Treated by Sesamol

Wu J, Luo D, Xu J

Breast Cancer: Targets and Therapy 2023, 15:391-401

Published Date: 29 May 2023

Radiomics Analysis of Breast Lesions in Combination with Coronal Plane of ABVS and Strain Elastography

Ma Q, Shen C, Gao Y, Duan Y, Li W, Lu G, Qin X, Zhang C, Wang J

Breast Cancer: Targets and Therapy 2023, 15:381-390

Published Date: 26 May 2023

ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion

Ahmad SMS, Nazar H, Rahman MM, Rusyniak RS, Ouhtit A

Breast Cancer: Targets and Therapy 2023, 15:373-380

Published Date: 24 May 2023

Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?

Dubrava AL, Kyaw PSP, Newman J, Pringle J, Westhuyzen J, La Hera Fuentes G, Shakespeare TP, Sakalkale R, Aherne NJ

Breast Cancer: Targets and Therapy 2023, 15:359-371

Published Date: 11 May 2023

Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review

Alghamdi MAA, Esam Mahmood S

Breast Cancer: Targets and Therapy 2023, 15:349-358

Published Date: 9 May 2023

Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications

da Silva JL, Carvalho GDS, Zanetti de Albuquerque L, Rodrigues FR, Fernandes PV, Kischinhevsky D, de Melo AC

Breast Cancer: Targets and Therapy 2023, 15:337-347

Published Date: 8 May 2023

Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study

Mery B, Ménétrier-Caux C, Montané L, Heudel PE, Ray-Coquard I, Bachelot T, Derbel O, Augereau P, Treilleux I, Berthet J, Nkodia A, Bardin-Dit-Courageot C, Attignon V, Ferrari A, Garin G, Perol D, Caux C, Dubois B, Trédan O

Breast Cancer: Targets and Therapy 2023, 15:311-325

Published Date: 27 April 2023

Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients

Shen J, Yan H, Yang C, Lin H, Li F, Zhou J

Breast Cancer: Targets and Therapy 2023, 15:295-310

Published Date: 25 April 2023

Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review

Wang J, Liao D, Zhang X, Miao C, Chen K

Breast Cancer: Targets and Therapy 2023, 15:281-294

Published Date: 21 April 2023

Breast Cancer Awareness Among Medical Students, University of Bisha, Saudi Arabia

Miskeen E, Al-Shahrani AM

Breast Cancer: Targets and Therapy 2023, 15:271-279

Published Date: 17 April 2023

Psychosocial Problems of Rural Indian Women Practising Breast Self-Examination – a Community-Based Study from Southern India

Balaiah Mehanathan P, Arthur Edwards Dennison A, Vikramathithan Panchapooranam A, Kandasamy S, Subbiah P, Velappan L, Kalyanaraman S

Breast Cancer: Targets and Therapy 2023, 15:263-270

Published Date: 17 April 2023

Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study

Koo DH, Lee KS, Sim SH, Chae H, Lee EG, Han JH, Jung SY, Lee S, Kang HS, Lee ES, Park CY, Oh SW

Breast Cancer: Targets and Therapy 2023, 15:251-261

Published Date: 14 April 2023

Clinicopathological Features and Survival Outcomes of Metaplastic Breast Carcinoma – An Observational Multi-Centric Study

Sherwani M, Vohra L, Ali D, Soomro R, Adnan S, Idrees R

Breast Cancer: Targets and Therapy 2023, 15:237-250

Published Date: 27 March 2023

Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk

Satish S, Moore JF, Littlefield JM, Bishop IJ, Rojas KE

Breast Cancer: Targets and Therapy 2023, 15:227-235

Published Date: 22 March 2023

Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer

Castellanos G, Valbuena DS, Pérez E, Villegas VE, Rondón-Lagos M

Breast Cancer: Targets and Therapy 2023, 15:189-211

Published Date: 9 March 2023

Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?

Emiroglu S, Özkurt E, Cabıoglu N, Igci A, Saip P, Yazici H, Ozmen T, Ozmen V, Muslumanoglu M, Tukenmez M

Breast Cancer: Targets and Therapy 2023, 15:163-173

Published Date: 21 February 2023

Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?

Jongbloed EM, Blommestein HM, van Schoubroeck HM, Martens JW, Wilting SM, Uyl-de Groot CA, Jager A

Breast Cancer: Targets and Therapy 2023, 15:147-161

Published Date: 16 February 2023

An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC

Zhang M, Bao S, Qiu G, Liang J, Wang Q, Zhu X, Qin G, Liu J, Zhao C

Breast Cancer: Targets and Therapy 2023, 15:101-119

Published Date: 3 February 2023

Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications

Prodhan ASU, Islam DZ, Khandker SS, Jamiruddin MR, Abdullah A, Godman B, Opanga S, Kumar S, Sharma P, Adnan N, Pisana A, Haque M

Breast Cancer: Targets and Therapy 2023, 15:51-89

Published Date: 27 January 2023

Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review

Badran O, Abu Amna M, Turgeman I, Bar-Sela G

Breast Cancer: Targets and Therapy 2023, 15:47-50

Published Date: 24 January 2023

Critical Evaluation of Secondary Cancer Risk After Breast Radiation Therapy with Hybrid Radiotherapy Techniques

Zhang Q, Zeng Y, Peng Y, Yu H, Zhang S, Wu S

Breast Cancer: Targets and Therapy 2023, 15:25-38

Published Date: 23 January 2023

Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer

Abdel-Razeq H, Abujamous L, Al-Azzam K, Abu-Fares H, Bani Hani H, Alkyam M, Sharaf B, Elemian S, Tamimi F, Abuhijla F, Edaily S, Salama O, Abdulelah H, Daoud R, Abubaker M, Al-Atary A

Breast Cancer: Targets and Therapy 2023, 15:1-10

Published Date: 13 January 2023

Chromobox Family Proteins as Putative Biomarkers for Breast Cancer Management: A Preliminary Study Based on Bioinformatics Analysis and qRT-PCR Validation

Tian H, Zhao T, Li Y, Sun N, Ma D, Shi Q, Zhang G, Chen Q, Zhang K, Chen C, Zhang Y, Qi X

Breast Cancer: Targets and Therapy 2022, 14:515-535

Published Date: 30 December 2022

Whole Genome Sequencing of Single-Circulating Tumor Cell Ameliorates Unraveling Breast Cancer Heterogeneity

Li Y, Jiang X, Zhong M, Yu B, Yuan H

Breast Cancer: Targets and Therapy 2022, 14:505-513

Published Date: 28 December 2022

Real-World Outcome and Prognostic Factors Among HER2-Positive Metastatic Breast Cancer Patients Receiving Pyrotinib-Based Therapy: A Multicenter Retrospective Analysis

Liu J, Sun X, Du Q, Yao J, Dai M, Cheng Q, Xu H, Li Y, Liu X, Zhang M, Zhou Y, Yang Y

Breast Cancer: Targets and Therapy 2022, 14:491-504

Published Date: 21 December 2022

Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment

Wu AH, Vigen C, Tseng C, Garcia AA, Spicer D

Breast Cancer: Targets and Therapy 2022, 14:433-451

Published Date: 9 December 2022

Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer

Yu Y, Wang J, Liao D, Zhang D, Li X, Jia Y, Kong F

Breast Cancer: Targets and Therapy 2022, 14:417-432

Published Date: 9 December 2022

Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer

Li Y, Ma X, Zhao Z, Li L, Gao C, Liu D, Li B, Zhao B

Breast Cancer: Targets and Therapy 2022, 14:405-415

Published Date: 6 December 2022

Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer

Almasri H, Erjan A, Abudawaba H, Ashouri K, Mheid S, Alnsour A, Abdel-Razeq H

Breast Cancer: Targets and Therapy 2022, 14:363-373

Published Date: 29 October 2022

Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer

Alsumai TS, Alhazzaa N, Alshamrani A, Assiri S, Alhefdhi A

Breast Cancer: Targets and Therapy 2022, 14:323-334

Published Date: 11 October 2022

More articles